Opioid Treatment and Premenstrual Disorders

This chapter explores opioid agonist medications, specifically methadone and buprenorphine, as primary treatments for opioid use disorder, detailing their benefits, risks, and the induction process. It also addresses the clinical diagnosis and treatment options for premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), underscoring the efficacy of SSRIs and other therapies. Additionally, it examines the role of cognitive behavioral therapy and complementary treatments like Vitex agnus castus in managing PMS and PMDD symptoms.